P53 pathway changes and their influence on chronic lymphoproliferative diseases pathogenesis
The role of p53 family proteins, both in the pathogenesis of chronic lymphoproliferative disorders, and in aspects of the growi ng interest in thetherapeutic potential of so-called small molecules capable of influencing the regulatory "relationship" of p53, MDM2, p21 and P UMA is currently...
Saved in:
| Main Authors: | P. M. Kondratovskiy, A. I. Dubikov, A. Yu. Doroshevskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2014-07-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/92 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the MDM2‐MDM4 interaction interface reveals an otherwise therapeutically active wild‐type p53 in colorectal cancer
by: Sonia Valentini, et al.
Published: (2025-08-01) -
The Role of Nuclear Phosphoinositides in the p53-MDM2 Nexus
by: Jeong Hyo Lee, et al.
Published: (2025-07-01) -
Bypassing the guardian: regulated cell death pathways in p53-mutant cancers
by: Jonathan Y. Chung, et al.
Published: (2025-06-01) -
VDAC2 Mediates the Apoptosis of Cashmere Goat Hair Follicle Stem Cells Through the P53 Signaling Pathway
by: Long Zhu, et al.
Published: (2025-06-01) -
An iASPP‐derived short peptide restores p53‐mediated cell death in cancers with wild‐type p53
by: Shi Qiu, et al.
Published: (2023-09-01)